Results 151 to 160 of about 6,997 (186)
Some of the next articles are maybe not open access.
Pediatric Clinics of North America, 1986
Myositis in childhood is characterized by elevated serum levels of muscle-derived enzymes, proximal symmetrical muscle weakness, abnormal EMG findings, and a muscle biopsy, which frequently documents an inflammatory process. In the pediatric age group, JDMS, which has characteristic cutaneous involvement in addition to myositis, is much more common ...
openaire +3 more sources
Myositis in childhood is characterized by elevated serum levels of muscle-derived enzymes, proximal symmetrical muscle weakness, abnormal EMG findings, and a muscle biopsy, which frequently documents an inflammatory process. In the pediatric age group, JDMS, which has characteristic cutaneous involvement in addition to myositis, is much more common ...
openaire +3 more sources
Panniculitis in Juvenile Dermatomyositis
Pediatric Dermatology, 1999Abstract: Panniculitis is a rarely reported clinical finding in dermatomyositis. We present a 14‐year‐old African American boy with a 4‐year history of dermatomyositis referred for evaluation of tender, indurated plaques and nodules on the trunk and proximal extremities.
F E, Ghali +3 more
openaire +2 more sources
HIV with Juvenile Dermatomyositis
The Indian Journal of Pediatrics, 2013Dermatomyositis with HIV infection has been very rarely reported. The authors report an 8-y-old boy who presented with skin rashes and edema, muscle weakness and polymicrobial infection along with mild immunosupression. Diagnosis of dermatomyositis was established by raised enzymes, suggestive MRI and muscle biopsy findings. Child responded to systemic
Varun Kumar, Sharma +4 more
openaire +2 more sources
Immunopathogenesis of juvenile dermatomyositis
Muscle & Nerve, 2010AbstractThere is increasing evidence for involvement of the mechanisms of the innate immune system in the pathogenesis of idiopathic inflammatory myopathies (IIMs), especially in the adult and juvenile forms of dermatomyositis. Juvenile dermatomyositis (JDM) is the most common form of childhood IIM, and this review focuses on recent advances in ...
Sahil, Khanna, Ann M, Reed
openaire +2 more sources
An update on juvenile dermatomyositis
Current Opinion in Rheumatology, 1995Juvenile dermatomyositis (JDMS) is a systemic vasculopathy characterized primarily by inflammation of skin and muscle. JDMS is identified in more than three per million persons per year, using established diagnostic criteria. Although originally thought to be a relatively homogeneous disease, new data confirm that heterogeneity in JDMS may be found at ...
openaire +2 more sources
Calcinosis in Juvenile Dermatomyositis
New England Journal of Medicine, 2019Calcinosis in Juvenile Dermatomyositis A 4-year-old girl with juvenile dermatomyositis presented with weakness, rash, and palpable subcutaneous nodules.
Jianguo, Li, Zhixuan, Zhou
openaire +2 more sources
Erythrodermic Juvenile Dermatomyositis
Pediatric Dermatology, 2009Abstract: Juvenile dermatomyositis (JDMS) is an inflammatory myopathy with various cutaneous manifestations, usually affecting children between 2 and 15 years of age. We describe a 9‐year‐old female diagnosed with Juvenile dermatomyositis presenting with generalized erythroderma, Gottron papules, inflammatory myopathy associated with systemic ...
Ram, Chander +3 more
openaire +2 more sources
Actuality of juvenile dermatomyositis
Joint Bone Spine, 2011Juvenile dermatomyositis is a rare disorder, but remains the most commonly occurring chronic inflammatory myopathy among children. Other than the proximal muscles and skin, which are routinely affected, vasculopathy may affect other viscera and can be multisystemic.
Amine, Zouagui +7 more
openaire +2 more sources
Juvenile dermatomyositis update
Current Rheumatology Reports, 2006Recent studies involving juvenile dermatomyositis indicate that the majority of affected children have symptoms suggestive of infection prior to disease onset, damage to skin and muscle each have a distinct pathophysiology, certain urinary muscle metabolites may be useful laboratory markers, and methotrexate used as first line therapy with ...
openaire +2 more sources
Proceedings of the Royal Society of Medicine, 1973
P S, Friedmann, R H, Marten
openaire +2 more sources
P S, Friedmann, R H, Marten
openaire +2 more sources